RenoVō® Equine Amniotic Tissue Allograft
RenoVō® equine allograft represents an advancement in regenerative veterinary science and medicine utilizing minimally manipulated equine amniotic tissue. Amniotic tissue possesses intrinsic anti-inflammatory, anti-microbial, anti-fibrotic and regenerative properties that make it attractive for use in veterinarian applications.
Just as the amniotic membrane and fluid provide biologic and physiologic properties and act as a physical barrier during pregnancy, Equine Amnio Solutions allografts provide physical and physiological properties to cover and protect tissues.
RenoVō® is an amniotic tissue allograft comprised of cytokines, growth factors and extracellular matrix proteins that are naturally found in amniotic tissues.
A prospective clinical study investigating the efficacy and safety of
RenoVō® for wound healing using an equine distal limbwound healing model is currently ongoing in partnership with the Oklahoma State University College of VeterinaryMedicine. In addition, a prospective case study investigating the outcomes of approximately 200 horses with soft tissue andorthopedic injuries using RenoVō® is nearing conclusion.
Cases under evaluation include:
Stifles for meniscal lesion
Carpus for intercarpal ligament tear
Lower hock joints
Desmitis of flexor tendons
Proximal suspensory ligament desmitis
Collateral ligaments of the coffin joint
Deep digital flexor tendon tear
Superficial digital flexor tendon tear
Potential Advantages of RenoVō®
Ready availability of a convenient allograft potentiates clinical use without the time lapse for culturing cells or harvesttechniques required for autologous therapies. Further, cytokine and growth factor profiles can vary dramatically betweenpatients for a selected autologous product. The protein content and reproducibility of each donor tissue may offer a moreconsistent product with similar or superior regenerative capacity. RenoVō® is cryopreserved and maintained frozen beforeuse, so as to preserve beneficial proteins that may not survive lyophilization. Clinicians currently using autologous stemcell or IRAP II™ System therapy should consider use of RenoVō® to achieve similar or improved clinical outcome
Dr. Marshall-Gibson and the Front Range Equine Performance Team are proud to be the first veterinarians in Colorado and Wyoming to use this new regenerative therapy. We work closely with the company and the veterinarians who pioneered this exciting new treatment in veterinary medicine to determine which patients RenoVō® will benefit.